Down-regulation of pigment epithelium-derived factor in uveitic lesion associates with focal vascular endothelial growth factor expression and breakdown of the blood-retinal barrier.
Spontaneous equine recurrent uveitis (ERU) is an incurable autoimmune disease affecting the eye. Identifying biological markers or pathways associated with this disease may allow the understanding of its pathogenesis at a molecular level. The vitreous is the body fluid closest to the disease-affected tissue and possibly also an effector of pathological processes relevant for ERU. Surgical removal of vitreous leads to cessation of relapses in spontaneous uveitis of both man and horse, therefore vitreous composites are likely to contribute to disease progression. Uveitic vitreous is likely to contain potential biomarkers in relatively undiluted quantities. With the goal to identify these markers, we systematically compared vitreous from healthy and disease-affected eyes by proteomic profiling. Nine differentially expressed proteins were identified, that are functionally related to immune response, inflammation, and maintenance of the blood-retinal barrier. One of these, pigment epithelium-derived factor, a protein involved in maintaining a proper blood-retina barrier as well as protecting from neoangiogenesis was additionally found to be down-regulated within uveitic retinal lesions whereas, conversely, vascular endothelial growth factor was found to be up-regulated at these sites. Together, these changes point to as of yet undiscovered biological pathways involved in the pathogenesis of this autoimmune disease.
Deeg
Cornelia A
CA
Institute of Animal Physiology, LMU Munich, Munich, Germany.
Altmann
Frank
F
Hauck
Stefanie M
SM
Schoeffmann
Stephanie
S
Amann
Barbara
B
Stangassinger
Manfred
M
Ueffing
Marius
M
D000818:Animals; D001813:Blood-Retinal Barrier / Q000502:physiology*; D015536:Down-Regulation; D015180:Electrophoresis, Gel, Two-Dimensional; D005136:Eye Proteins / Q000096:biosynthesis*; D006734:Horse Diseases / Q000503:physiopathology*; D006736:Horses; D009414:Nerve Growth Factors / Q000096:biosynthesis*; D020543:Proteome / Q000737:chemistry*; D015843:Serpins / Q000096:biosynthesis*; D014605:Uveitis / Q000662:veterinary*; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis*; D000099174:Pigment Epithelium-Derived Factor
D005136:Eye Proteins; D009414:Nerve Growth Factors; D020543:Proteome; D015843:Serpins; D042461:Vascular Endothelial Growth Factor A; D000099174:Pigment Epithelium-Derived Factor